OnTarget Laboratories says a pair of investors put $15 million into its technology designed to cause tumorous tissue to fluoresce.
OnTarget Laboratories said it landed a $15 million investment from a pair of backers for its tumor-lighting technology developed at Purdue University by the founder of Endocyte (NSDQ:ECYT).
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1iwefWN
Cap comentari:
Publica un comentari a l'entrada